Clinical Trials on 杂项肿瘤,NOS in Japan
总计2795个结果
-
Japan Clinical Oncology GroupMinistry of Health, Labour and Welfare, Japan完全的
-
Takeda完全的复发或难治性 CD30+ 霍奇金淋巴瘤或间变性大细胞淋巴瘤日本
-
Eli Lilly and Company完全的
-
Eli Lilly and Company完全的
-
Merck Sharp & Dohme LLC完全的
-
GlaxoSmithKline完全的Leukaemia, Lymphocytic, Chronic and Lymphoma, Follicular日本
-
Bayer主动,不招人
-
Kyowa Kirin Co., Ltd.完全的
-
Novartis Pharmaceuticals终止
-
Celgene Corporation终止
-
Kyushu UniversityHuman Genome Center, Institute of Medical Science, University of Tokyo完全的
-
AstraZeneca完全的Healthy Japanese Young and Elderly Male and Non-fertile Female Volunteers日本
-
Kyowa Kirin Co., Ltd.完全的
-
EPS Corporation完全的Liver Only Metastasis From KRAS Exon 2 Wild Type (Under Protocol 1.0-1.2 Edition) and RAS Wild Type (Under Protocol 2.0 Edition) Colorectal Cancer日本
-
Japan Clinical Oncology GroupMinistry of Health, Labour and Welfare, Japan终止